Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The OPAT opportunity for beta-lactam individualization

Antimicrobial Stewardship & Healthcare Epidemiology(2024)10.1017/ash.2024.367Source: DataRank Database

The OPAT opportunity for beta-lactam individualization is a research paper published in Antimicrobial Stewardship & Healthcare Epidemiology (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.31)OA: goldTopics (18)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Christina G. Rivera ORCID,Veena Venugopalan ORCID,Madelyn J Johnson,Erin F. Barreto ORCID,Lindsey M. Childs‐Kean ORCID

Live enrichment

PubMed:39257422 PMC:PMC11384153 OpenAlex:https://openalex.org/W4402236359

NIAID NIH HHS

Grant: K23 AI143882

National Institutes of Health

Grant: 5K23AI143882-05

Beta-lactam individualization for critically ill patients

FWCI

1.31

Citation Percentile

0.8%

Influential Citations

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/98FE8360C283309999A28CB2EEA12A7E/S2732494X2400367Xa.pdf/div-class-title-the-opat-opportunity-for-beta-lactam-individualization-div.pdf

GOLDhttps://doi.org/10.1017/ash.2024.367

publisherhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/98FE8360C283309999A28CB2EEA12A7E/S2732494X2400367Xa.pdf/div-class-title-the-opat-opportunity-for-beta-lactam-individualization-div.pdf

publisherhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/S2732494X2400367X

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39257422

Fields of Study

Antibiotics Pharmacokinetics and EfficacyAntibiotic Use and ResistanceAnalytical Methods in PharmaceuticalsMedicine0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MedicineIntensive care medicineBeta-lactamAntimicrobialAntibioticsMicrobiologyConcise CommunicationInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270

Sustainable Development Goals

SDG 0: Good health and well-being